| Metric | FY 2025 | Prior Q | FY 2024 | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Revenue | $1.9B | — | $1.8B | — | 6.3% |
| Op. Income | $518M | — | $428M | — | 21.2% |
| Gross Margin | 29.8% | — | 25.7% | — | 4.1pp |
| Net Margin | 21.4% | — | 19.5% | — | 1.9pp |
| EPS (Diluted) | $4.36 | — | $3.74 | — | 16.6% |
| Free Cash Flow | $609M | — | $556M | — | 9.6% |
| Item | Amount |
|---|---|
| REVENUE | $1.9B |
| Cost of Revenue | $1.3B |
| GROSS PROFIT | $561M |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $46M |
| SG&A Expenses | $46M |
| Other Expenses | -$3M |
| Operating Expenses | $43M |
| Cost & Expenses | $1.4B |
| OPERATING INCOME | $518M |
| Interest Income | $0 |
| Interest Expense | $5M |
| Other Income/Expenses | -$12M |
| INCOME BEFORE TAX | $506M |
| Income Tax Expense | $103M |
| Net Income from Continuing Ops | $403M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $403M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $403M |
| D&A | $8M |
| EBIT | $522M |
| EBITDA | $530M |
| EPS | $4 |
| EPS Diluted | $4 |
| Item | Amount |
|---|---|
| REVENUE | $1.9B |
| Cost of Revenue | $1.3B |
| GROSS PROFIT | $561M |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $46M |
| SG&A Expenses | $46M |
| Other Expenses | -$3M |
| Operating Expenses | $43M |
| Cost & Expenses | $1.4B |
| OPERATING INCOME | $518M |
| Interest Income | $0 |
| Interest Expense | $5M |
| Other Income/Expenses | -$12M |
| INCOME BEFORE TAX | $506M |
| Income Tax Expense | $103M |
| Net Income from Continuing Ops | $403M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $403M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $403M |
| D&A | $8M |
| EBIT | $522M |
| EBITDA | $530M |
| EPS | $4 |
| EPS Diluted | $4 |
| Item | Amount |
|---|---|
| Net Income | $403M |
| Depreciation & Amortization | $8M |
| Stock-Based Compensation | $0 |
| Deferred Income Tax | $0 |
| Other Non-Cash Items | -$47M |
| Change in Working Capital | $250M |
| OPERATING CASH FLOW | $614M |
| Capital Expenditure | -$6M |
| Acquisitions (Net) | $0 |
| Purchases of Investments | -$1.5B |
| Sales/Maturities of Investments | $1.1B |
| Other Investing Activities | $1M |
| NET CASH FROM INVESTING | -$362M |
| Net Debt Issuance | $0 |
| Common Stock Repurchased | $0 |
| Common Dividends Paid | -$242M |
| Other Financing Activities | $0 |
| NET CASH FROM FINANCING | -$240M |
| FREE CASH FLOW | $609M |
| Net Change in Cash | $12M |
| Item | Amount |
|---|---|
| Cash & Equivalents | $52M |
| Short-Term Investments | $121M |
| Net Receivables | $212M |
| Inventory | $0 |
| Other Current Assets | -$212M |
| TOTAL CURRENT ASSETS | $172M |
| PP&E (Net) | $41M |
| Goodwill | $46M |
| Intangible Assets | $8M |
| Long-Term Investments | $0 |
| Tax Assets | $0 |
| Other Non-Current Assets | $0 |
| TOTAL NON-CURRENT ASSETS | $94M |
| TOTAL ASSETS | $6.2B |
| Account Payables | $41M |
| Short-Term Debt | $100M |
| Deferred Revenue | $867M |
| Other Current Liabilities | -$908M |
| TOTAL CURRENT LIABILITIES | $130M |
| Long-Term Debt | $0 |
| Deferred Revenue NC | $0 |
| Deferred Tax Liabilities | $22M |
| Other Non-Current Liabilities | $4.2B |
| TOTAL NON-CURRENT LIABILITIES | $4.3B |
| TOTAL LIABILITIES | $4.4B |
| Common Stock | $1M |
| Additional Paid-In Capital | $377M |
| Retained Earnings | $1.9B |
| Treasury Stock | -$407M |
| Accum. Other Comp. Income | -$74M |
| Other Equity | $0 |
| TOTAL STOCKHOLDERS' EQUITY | $1.8B |
| Minority Interest | $0 |
| TOTAL EQUITY | $1.8B |
| TOTAL LIABILITIES & EQUITY | $6.2B |
| Total Debt | $100M |
| Net Debt | $48M |
